NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
18.06
-0.80 (-4.24%)
Mar 31, 2025, 9:55 AM EDT - Market open
NovoCure Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for NovoCure stock have an average target of 37.5, with a low estimate of 30 and a high estimate of 42. The average target predicts an increase of 107.64% from the current stock price of 18.06.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 14, 2025.
Analyst Ratings
The average analyst rating for NovoCure stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +110.41% | Jan 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $28 → $42 | Buy | Maintains | $28 → $42 | +132.56% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $38 | Strong Buy | Maintains | $30 → $38 | +110.41% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 → $38 | Strong Buy | Reiterates | $30 → $38 | +110.41% | Dec 2, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $18 → $30 | Hold → Buy | Upgrades | $18 → $30 | +66.11% | Dec 2, 2024 |
Financial Forecast
Revenue This Year
625.86M
from 605.22M
Increased by 3.41%
Revenue Next Year
683.70M
from 625.86M
Increased by 9.24%
EPS This Year
-2.09
from -1.56
EPS Next Year
-2.12
from -2.09
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 669.9M | 737.1M | 910.5M | ||
| Avg | 625.9M | 683.7M | 796.0M | ||
| Low | 582.1M | 602.0M | 698.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.7% | 17.8% | 33.2% | ||
| Avg | 3.4% | 9.2% | 16.4% | ||
| Low | -3.8% | -3.8% | 2.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.79 | -1.55 | -0.92 | ||
| Avg | -2.09 | -2.12 | -1.50 | ||
| Low | -2.73 | -2.53 | -2.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.